Therapeutic target discovery using Caenorhabditis elegans

Author： Link Elizabeth M   Hardiman Gary   Sluder Ann E   Johnson Carl D   Liu Leo X  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.1, Iss.2, 2000-05, pp. : 203-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Using Caenorhabditis elegans for antimicrobial drug discovery

By Desalermos Athanasios   Muhammed Maged   Glavis-Bloom Justin   Mylonakis Eleftherios  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 6, 2011-06 ,pp. : 645-652

Informa Healthcare

Access to resources Recommend Favorite

Caenorhabditis elegans-based Model Systems for Antifungal Drug Discovery

By  

Current Pharmaceutical Design, Vol. 17, Iss. 13, 2011-05 ,pp. : 1225-1233

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Pesticide Toxicities with Differing Mechanisms Using Caenorhabditis elegans

By Ruan Qin-Li   Ju Jing-Juan   Li Yun-Hui   Liu Ran   Pu Yue-Pu   Yin Li-Hong   Wang Da-Yong  

Journal of Toxicology and Environmental Health, Vol. 72, Iss. 11-12, 2009-01 ,pp. : 746-751

Taylor & Francis Ltd

Access to resources Recommend Favorite

Drug target discovery using retroviruses

By Blø Magnus   Micklem David R   Lorens James B  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1285-1300

Informa Healthcare

Access to resources Recommend Favorite

Cancer target discovery using SAGE

By Porter Dale   Polyak Kornelia  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 759-769

Informa Healthcare

Access to resources Recommend Favorite